pr104
Showing 1 - 5 of 5
NSCLC Trial in Canada, New Zealand, United States (PR104, docetaxel, Granulocyte colony-stimulating factor)
Terminated
- Non-Small Cell Lung Cancer
- PR104
- +2 more
-
San Diego, California
- +26 more
Jan 8, 2013
Lung Cancer Trial in United States (PR104, F-18-fluoromisonidazole)
Terminated
- Lung Cancer
- PR104
- F-18-fluoromisonidazole
-
Tucson, Arizona
- +17 more
Dec 6, 2012
Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia Trial in Houston, Seattle (PR104)
Unknown status
- Acute Myelogenous Leukemia
- Acute Lymphocytic Leukemia
- PR104
-
Houston, Texas
- +1 more
Aug 30, 2012
Solid Tumor Trial in Scottsdale, San Antonio, Hamilton (biological, drug, other)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- filgrastim
- +2 more
-
Scottsdale, Arizona
- +2 more
May 31, 2011
Solid Tumor Trial in Auckland, Waikato (PR104)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- PR104
-
Auckland, New Zealand
- +1 more
May 23, 2011